未接受他汀类药物治疗与10年动脉粥样硬化性心血管疾病风险评分同关节镜下肩袖修复术后再撕裂率的关系
本研究为病例对照研究,纳入182例接受关节镜下全层肩袖撕裂修复的患者,评估血脂、10年ASCVD风险评分及他汀使用状态与再撕裂的关系。多因素回归显示未接受他汀治疗、10年ASCVD风险评分及冈下肌脂肪浸润为再撕裂独立相关因素。在104例符合他汀治疗指征的患者中,未接受他汀治疗组再撕裂率显著高于接受他汀治疗组(36.8% vs 13.6%,P=0.006)。
要点
- 未接受他汀治疗、10年ASCVD风险评分和冈下肌脂肪浸润是肩袖修复后再撕裂的独立相关因素。
- 10年ASCVD风险评分预测再撕裂的截断值为11.85%,敏感度0.75,特异度0.62。
- 符合他汀治疗指征但未接受他汀治疗的患者再撕裂率显著高于接受他汀治疗者(36.8% vs 13.6%,P=0.006)。
核心结论
- 未接受他汀治疗、10年ASCVD风险评分和冈下肌脂肪浸润是与肩袖再撕裂独立相关的因素。
- 未接受他汀治疗的患者再撕裂率高于接受他汀治疗的患者。
- 对接受关节镜下肩袖修复的患者,优化他汀治疗可能改善修复完整性。
研究设计与样本
- 病例对照研究,证据等级3级。
- 纳入182例接受关节镜下全层肩袖撕裂修复的有症状患者。
- 评估血清血脂谱、10年ASCVD风险评分、他汀治疗指征及他汀使用状态。
- 根据术后6个月磁共振成像评估肩袖完整性,将患者分为愈合组和再撕裂组。
- 对符合他汀治疗指征的患者按是否接受他汀治疗进行亚组分析。
主要发现
- 愈合组149例(81.9%),再撕裂组33例(18.1%)。
- 多因素回归分析显示未接受他汀治疗、10年ASCVD风险评分和冈下肌脂肪浸润是再撕裂的独立相关因素。
- 10年ASCVD风险评分预测再撕裂的截断值为11.85%,敏感度0.75,特异度0.62。
- 在104例符合他汀治疗指征的患者中,66例(63.5%;组1)接受他汀治疗,38例(36.5%;组2)未接受他汀治疗。
- 组2再撕裂率显著高于组1(36.8% vs 13.6%;P=0.006)。
关键数值与推荐
- 10年ASCVD风险评分预测再撕裂的截断值为11.85%,敏感度0.75,特异度0.62。
- 符合他汀治疗指征的患者中,接受他汀治疗组再撕裂率为13.6%,未接受他汀治疗组为36.8%(P=0.006)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is no practical consensus on managing cholesterol in patients with rotator cuff repair despite hyperlipidemia and statin therapy being well-known factors in rotator cuff healing. The 10-year atherosclerotic cardiovascular disease (ASCVD) risk score is a commonly used guideline to determine statin administration for hyperlipidemia. PURPOSE: To identify the relationship between retear and preoperative factors, including 10-year ASCVD risk score and statin administration status, and to compare clinical outcomes and retear rates between patients who are taking and not taking statins. STUDY DESIGN: Case-control study; Level of evidence, 3. METHODS: This study enrolled 182 patients with a symptomatic full-thickness rotator cuff tear who underwent arthroscopic repair. Serum lipid profile, 10-year ASCVD risk score, statin eligibility, and statin administration status were assessed. Patients were categorized into 2 groups based on magnetic resonance imaging to evaluate cuff integrity at postoperative 6 months: a healed group and a retear group. Radiographic and intraoperative factors related to retear were analyzed. Multiple regression analysis was performed to evaluate factors related to rotator cuff retear. For the subgroup analysis, patients eligible for statin therapy were divided into 2 subgroups according to administration status. RESULTS: There were 149 (81.9%) patients in the healed group and 33 (18.1%) in the retear group. In the multiple regression analysis, missed statin therapy, 10-year ASCVD risk score, and fatty infiltration of the infraspinatus muscle were the independent factors related to retear. The cutoff value for 10-year ASCVD risk score was 11.85%, with a sensitivity of 0.75 and a specificity of 0.62. In the subgroup analysis of 104 patients eligible for statin therapy, 66 (63.5%; group 1) received statin therapy and 38 (36.5%; group 2) missed it. Group 2 showed a significantly higher retear rate than group 1 (36.8% vs 13.6%; P = .006). CONCLUSION: Missed statin therapy, 10-year ASCVD risk score, and fatty infiltration of the infraspinatus were the independent factors associated with rotator cuff retear. Patients who missed statin therapy showed a higher retear rate than patients receiving statin therapy. Optimal statin therapy for patients who undergo arthroscopic rotator cuff repair might improve repair integrity.
引用
- Lee S, Lee N, Shin SJ, et al. Relationship of Missed Statin Therapy and 10-Year Atherosclerotic Cardiovascular Disease Risk Score to Retear Rate After Arthroscopic Rotator Cuff Repair. Am J Sports Med. 2023. PMID: 37259963. doi:10.1177/03635465231175476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。